Sherlock Biosciences announces clinical data from Dartmouth-Hitchcock Health’s pilot study of Sherlock CRISPR SARS-CoV-2 Kit
Data shows 100% concordance with real patient samples; study supports CRISPR-based test diagnostic accuracy to detect COVID-19